MENU
EIKN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Eikon Therapeutics (EIKN) Ownership - Who owns Eikon Therapeutics?

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs... Show more

Profile

Industry
N/A
Address
230 Harriet Tubman Way
Phone
+1 341 777-0566
Employees
384
Web
https://www.eikontx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
433.32M
P/E Ratio
-1.34
Total Cash
531.18M
Projected Growth
N/A
Total Debt
252.22M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Eikon Therapeutics? EIKN symbol Ownership - Tickeron.com